Overview
A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers
Status:
Terminated
Terminated
Trial end date:
2009-04-01
2009-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Investigation of safety, tolerability, and pharmacokinetics of PF-00868554 following multiple oral administrations of PF-00868554 in Japanese healthy adult volunteers.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- Healthy male and female Japanese subjects between the ages of 18 and 55 years.
- Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs).
Exclusion Criteria:
- Male subjects with a history of subfertility/infertility and other conditions that in
the opinion of the investigator may affect fertility.
- Exposure within the previous three months to a drug known to have a negative effect on
skeletal muscle or reproductive organs.
- Pregnant or nursing females; females of childbearing potential.